Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 03, 2026
Why Is International Business Machines (IBM) Stock Down -5% Today?

Why Is International Business Machines (IBM) Stock Down -5% Today?

Key Takeaways

  • IBM shares are declining approximately 5% in Wednesday's session, pulling back from a prior close of $320.42
  • The primary driver is profit-taking after an extraordinary two-week rally that saw shares surge more than 25%, fueled by a $10 billion quantum computing investment and a bullish Barclays initiation at Overweight with a $350 price target
  • Broader risk-off sentiment is adding pressure, with the ISM Non-Manufacturing data released this morning contributing to macro uncertainty
  • The technology and software sector continues to face valuation headwinds in 2026, and IBM's recent sharp run-up left the stock technically extended
  • Traders are watching whether IBM can hold recent breakout levels and whether the quantum computing narrative maintains its momentum heading into Q2 2026 earnings

Opening Summary

International Business Machines Corporation (IBM) is a global technology and consulting leader offering hybrid cloud platforms, artificial intelligence solutions, quantum computing infrastructure, and enterprise IT services. Shares are trading down roughly 5% on Wednesday, June 3, 2026, moving from a prior session close of $320.42 toward the $306–$307 range. The decline follows a spectacular late-May rally in which IBM surged more than 25% in just over a week — a run that appears to be triggering a healthy round of profit-taking as traders lock in gains from one of the sharpest short-term rallies in the stock's recent history.

Profit-Taking After a Historic Rally

The immediate driver behind today's price decline is straightforward: IBM ran too far, too fast. On May 29, shares jumped 12.6% in a single session after the company announced a $10 billion, five-year commitment to quantum computing backed by the CHIPS Act. That momentum carried into June 1, when Barclays initiated coverage with an Overweight rating and a $350 price target, sending shares up another 10% and pushing IBM to its highest level in over a year. After gaining roughly 25% in fewer than five trading days, profit-taking pressure was all but inevitable — investors who bought on weakness throughout 2026 are now exiting with strong gains.

Quantum Catalyst Fades, Valuation Concerns Return

While the quantum computing announcement and Barclays initiation were powerful short-term catalysts, investors are now stepping back to assess whether IBM's fundamentals justify the elevated price level. The stock had spent most of 2026 as a notable laggard among mega-cap technology names, shedding as much as 25% year-to-date at its trough in mid-May. The rapid re-rating raises legitimate questions: the $10 billion quantum commitment spans five years and will not immediately translate into revenue, while IBM's Q1 2026 results — which beat estimates — were still met with selling as investors found the margin of outperformance underwhelming. The market is now recalibrating between the long-term quantum narrative and the near-term reality of slowing consulting and software growth.

Macro Pressures and Sector Headwinds

Beyond company-specific dynamics, today's session is unfolding against a cautious macro backdrop. ISM Non-Manufacturing data released this morning is contributing to uncertainty about the pace of U.S. economic activity, a key concern for enterprise software and consulting firms like IBM that rely on corporate IT spending. The broader technology sector has faced persistent valuation compression throughout 2026, with growth names penalized by rate sensitivity and concerns over the long-term impact of generative AI on legacy IT services business models. Peer AI-facing technology stocks are showing mixed performance Wednesday, reflecting the sector-wide caution.

Market Context and Trading Activity

Today's volume is elevated relative to IBM's 65-day average of approximately 4.69 million shares, consistent with active institutional repositioning following the late-May surge. The stock opened at $313.75 and has extended losses through the morning session. From a technical standpoint, the sharp pullback is occurring after IBM broke above its 52-week high near $332 in recent sessions — a level that often attracts short-sellers and profit-takers simultaneously. The broader Dow Jones Industrial Average, of which IBM is a component, is also under mild pressure, though IBM's decline is outpacing the index, indicating stock-specific dynamics are the dominant force.

Trending AI Robots

For active traders navigating volatile sessions like today's, Tickeron's Trending AI Robots page provides a curated window into the platform's highest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-powered bots covering thousands of tickers across equities, ETFs, and sectors — but the Trending AI Robots section highlights only those bots demonstrating the strongest live performance metrics at any given time. Each bot differs by strategy type (momentum, mean reversion, breakout), trading timeframe, risk profile, and the specific instruments it trades, allowing users to match tools to their own approach. Whether you are trading large-cap tech names or navigating sector rotations, exploring the trending bots can offer a data-driven advantage in fast-moving markets.

What Comes Next for IBM

The next major catalyst for IBM is its Q2 2026 earnings report, which will provide critical insight into whether the quantum computing investment has begun driving incremental revenue or bookings, and whether consulting and software segments are recovering from earlier weakness in the year. Analysts currently hold a consensus Buy rating on the stock, with Wall Street closely monitoring the pace of Confluent integration following IBM's acquisition and RedHat's growth trajectory in a competitive hybrid cloud market. Key risks include a broader tech sector de-rating, continued pressure on enterprise IT spending budgets, and the possibility that the quantum computing narrative — however compelling long-term — struggles to sustain near-term price momentum without tangible revenue updates. On the upside, IBM's deepening partnership with Nvidia across cloud services, enterprise hardware, and data storage infrastructure represents a credible long-term growth angle that analysts continue to evaluate.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: IBM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


IBM in upward trend: 10-day moving average crossed above 50-day moving average on September 14, 2026

The 10-day moving average for IBM crossed bullishly above the 50-day moving average on September 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 377 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 159 of 264 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBM as a result. In 46 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.

The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 23 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

IBM moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

IBM broke above its upper Bollinger Band on September 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.165) is normal, around the industry mean (7.607). P/E Ratio (20.028) is within average values for comparable stocks, (68.252). Projected Growth (PEG Ratio) (2.133) is also within normal values, averaging (2.294). IBM has a moderately high Dividend Yield (0.030) as compared to the industry average of (0.010). P/S Ratio (3.271) is also within normal values, averaging (143.514).

The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 8.62B. The market cap for tickers in the group ranges from 100 to 212.46B. IBM holds the highest valuation in this group at 212.46B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was -5%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was 13%. INOD experienced the highest price growth at 21%, while WYY experienced the biggest fall at -57%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was -58%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -70%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 64
Price Growth Rating: 60
SMR Rating: 72
Profit Risk Rating: 92
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
IBM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of various computer products through the use of advanced information technology

Industry InformationTechnologyServices

Industry
Information Technology Services
Address
One New Orchard Road
Phone
+1 914 499-1900
Employees
286800
Web
https://www.ibm.com
Interact to see
Advertisement
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
AUGO shares are trading roughly 9% higher in Wednesday action, moving from a prior close of $66.42 to around $72.40 intraday. The stock’s advance extends a powerful year-long rally underpinned by record 2025 production, surging Adjusted EBITDA, and a recently declared cash dividend of $0.66 per share.
NAVN shares are surging approximately +25% in premarket trading on March 26, 2026, following a blockbuster earnings report released after the close of the prior session. Primary catalyst: Q4 fiscal year 2026 results delivered a significant beat — revenue of $178 million rose 35% year-over-year, surpassing analyst forecasts by nearly 10%.
OLPX surged approximately +50.38% in premarket trading on March 26, 2026, from a previous close of $1.33 to approximately $2.00, with an intraday premarket high of $2.03. The primary catalyst is a definitive acquisition agreement by German consumer goods giant Henkel AG to purchase Olaplex for $2.06 per share in an all-cash deal, valuing the company at approximately $1.4 billion.
TASK shares are down approximately -36% in premarket trading on March 26, 2026, the stock's official ex-dividend date for its special $3.65 per share cash dividend. The $3.65 special cash dividend — exceeding 25% of the stock's pre-ex-div market value — triggered a mandatory Nasdaq-prescribed price adjustment on today's open.
MLKN shares are down approximately 18.90% in premarket trading on March 26, 2026, falling to $15.70 from the prior session's close of $19.36. The primary catalyst is a double miss on both earnings and revenue in the company's fiscal Q3 2026 report released after the close on March 25.
Wave Life Sciences (WVE) shares are tumbling approximately 51% in premarket trading on March 26, 2026, from a prior close of $12.30 to approximately $6.03. The primary catalyst is the release of highly anticipated INLIGHT Phase 1 clinical data for WVE-007, the company's investigational INHBE GalNAc-siRNA obesity treatment, with results falling materially short of investor expectations.
Why Is International Business Machines (IBM) Stock Down -5% Today?